Skip to Content
  •  
  •  
  •  

NOTICE OF SETTLEMENT: Vanda Pharmaceuticals Inc. Derivative Litigation

Corporate Governance / Derivative

Overview

Overview

  • Date:
  • 7/21/2021
  • Case Caption:
  • In re Vanda Pharmaceuticals Inc. Derivative Litigation
  • Stock Symbol:
  • VNDA
  • Status:
  • Settled
  • Settlement Status:
  • Preliminary Approval
  • Court:
  • U.S. District Court: Eastern District of New York

Case Finder

Locate any case using the tools below.

NEW YORK, September 30, 2021 - Bragar Eagel & Squire P.C. announces that the United States District Court for the Eastern District of New York granted final approval of the settlement of the derivative action captioned In re Vanda Pharmaceuticals Inc. Derivative Litigation, Case No. 1:19-cv-04293-FB-LB.

If you were a stockholder of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) as of July 19, 2021 and continue to own such shares, please click HERE to read the Notice to Current Vanda Stockholders, which contains important information regarding your rights.

Please reach out to counsel for Plaintiffs with any questions or concerns at:
 
Counsel for Plaintiffs:
Gregory M. Nespole
Daniel Tepper
LEVI & KORSINSKY, LLP
55 Broadway, 10th Floor
New York NY 10006
Fax: (212) 363-7171
 
W. Scott Holleman
Garam Choe
BRAGAR EAGEL & SQUIRE, P.C.
810 Seventh Avenue, Suite 620
New York, NY 10019
Fax: (212) 486-0462

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: